Legal & General Group PLC Opti Nose, Inc. Transaction History

Legal & General Group PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$1.17 - $1.94 $2,728 - $4,524	-2,332 Reduced 26.02%	6,629 $9,000
Q2 2023 Aug 14, 2023	BUY	$1.11 - $2.05 $9,946 - $18,370	8,961 New	8,961 $11,000
Q2 2021 Aug 12, 2021	SELL	$2.91 - $3.83 $11,282 - $14,848	-3,877 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$3.69 - $7.09 $4,357 - $8,373	-1,181 Reduced 23.35%	3,877 $15,000
Q2 2020 Aug 14, 2020	BUY	$3.58 - $7.44 $3,411 - $7,090	953 Added 23.22%	5,058 $38,000
Q1 2020 May 14, 2020	SELL	$3.49 - $9.2 $4,170 - $10,994	-1,195 Reduced 22.55%	4,105 $18,000
Q4 2019 Feb 13, 2020	BUY	$6.27 - $11.41 $7,066 - $12,859	1,127 Added 27.01%	5,300 $49,000
Q2 2019 Aug 14, 2019	BUY	$6.4 - $10.94 $7,673 - $13,117	1,199 Added 40.32%	4,173 $27,000
Q3 2018 Nov 20, 2018	BUY	$12.43 - $29.76 $7,283 - $17,439	586 Added 24.54%	2,974 $37,000
Q2 2018 Aug 10, 2018	BUY	$18.75 - $28.46 $27,187 - $41,267	1,450 Added 154.58%	2,388 $67,000
Q4 2017 Feb 13, 2018	BUY	$15.2 - $20.76 $14,257 - $19,472	938	938 $18,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $45M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.